Provides integrated healthcare services in Canada. Offers customized specialty healthcare solutions. Now — the numbers.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly below the class average.
Growth: Sales growth trails the sector average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Trading Liquidity: The shares change hands too rarely for smooth trading.
An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
It pays out $0.05 per share each year — regular cash for whoever holds the stock.
The growth engine is running at low revs right now. Report-card grade: 1/100.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 7/100. For a turnaround signal, the stock first needs to close the gap with the market.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 24/100.
On our five-subject report card, SRXH sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: revenue and profit, the growth trend, the balance sheet, the revenue breakdown.